Pelthos Therapeutics (PTHS) EBITDA (2023 - 2026)
Pelthos Therapeutics (PTHS) posted quarterly EBITDA of -$12.0 million for Q4 2025, down 558.06% year-over-year from $2.6 million in Q4 2024, and up 21.87% quarter-over-quarter from -$15.4 million in Q3 2025.
Pelthos Therapeutics (PTHS) EBITDA (2023 - 2026) Analysis & Trends
Pelthos Therapeutics' EBITDA history runs 3 years deep, the most recent figure standing at -$12.0 million for Q4 2025.
- In Q4 2025, EBITDA fell 558.06% year-over-year to -$12.0 million; the TTM figure through Dec 2025 stood at -$32.4 million (down 328.33% YoY), while the FY2025 annual figure was -$32.4 million, down 328.35% from the prior year.
- EBITDA for Q4 2025 stood at -$12.0 million, up from -$15.4 million in the prior quarter.
- The five-year high for EBITDA was -$777160.0 in Q2 2023, with the low at -$15.4 million in Q3 2025.
- The 3-year median for EBITDA is -$1.9 million (2024), against an average of -$3.9 million.
- The sharpest annual moves came in 2024 and 2025: EBITDA soared 52.98% in 2024, then plunged 649.73% in 2025.
- Pelthos Therapeutics' EBITDA stood at -$3.9 million in 2023, then jumped by 52.98% to -$1.8 million in 2024, then slumped by 558.06% to -$12.0 million in 2025.
- Business Quant data shows PTHS's EBITDA at -$12.0 million in Q4 2025, -$15.4 million in Q3 2025, and -$3.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -815.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 325.05 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 231.44 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -1.55 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 133.12 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -375.75 Mn |
| 10 | Pelthos Therapeutics | 96.56 Mn | 72.00 Mn | 21.23 Mn | -30.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -30.41 Mn |
| Dec 31, 2025 | -12.00 Mn |
| Sep 30, 2025 | -15.36 Mn |
| Jun 30, 2025 | -3.23 Mn |
| Mar 31, 2025 | -1.83 Mn |
| Dec 31, 2024 | -1.82 Mn |
| Sep 30, 2024 | -2.05 Mn |
| Jun 30, 2024 | -1.76 Mn |
| Mar 31, 2024 | -1.93 Mn |
| Dec 31, 2023 | -3.88 Mn |
| Sep 30, 2023 | -1.29 Mn |
| Jun 30, 2023 | -777,160.00 |
| Mar 31, 2023 | -914,583.00 |